Healthcare Industry Cost of Capital: Does it Vary by Segment?

Will Hamilton • September 10, 2018
One of the things we track closely is fairness opinions that get filed with the SEC when a public company gets taken private. It's always interesting to see the revenue and adjusted EBITDA projections prepared by management, as well as the comps used in the market approach section. Also interesting, and of relevance to anyone who develops a discount rate on occasion, is the cost of capital used by the bankers who prepare the analyses.

We keep a database of key information from and links to fairness opinions. We've sliced and diced the data a bit to see what factors seem to impact the cost of capital selected by the preparers the most (technical note - these represent midpoints of the range for each company, and exclude unprofitable and development stage companies). Keep in mind these are publicly-traded companies being taken private, so think large, diversified corporations.

Pharmacy came in the lowest, which was primarily due to the fact that one of the three data points was CVS, which is both the largest and had the lowest selected cost of capital. Tied for highest were medical transportation and specialty outpatient facilities, which may be is influenced by three older deals with high cost of capital estimates. The two more recent specialty outpatient deals actually had cost of capital estimates of 7.0% and 7.5% respectively.

 

Overall, there isn't much spread between segments, and the outliers seem to be explained better by other factors. Size, for example, clearly has a significant impact. We've previously discussed discussed the impact of size on valuation using a different data set.

Even timing may have a larger impact, as cost of capital estimates have decreased over the past several years.

Shoot us an email if you want to take a look at the full workbook.

Hand Touching Plus
By Will Hamilton February 11, 2019
We ranked the 30 largest healthcare services and information technology deals of 2018, according to our database, by valuation multiple. The lowest reported price to EBITDA multiples (10x or lower, sorted alphabetically) are listed below.
Man touching gears.
By Will Hamilton January 8, 2019
We ranked the 30 largest healthcare services and information technology deals of 2018, according to our database, by valuation multiple.
Business man
By Will Hamilton January 8, 2019
We ranked the 30 largest healthcare services and information technology deals of 2018, according to our database, by valuation multiple. The highest reported price to EBITDA multiples (15x or higher, sorted alphabetically) were as follows:
Man holding brain
By Will Hamilton January 3, 2019
Healthcare services organizations rely on a variety of intangible assets to create business value, including patient and customer relationships, medical records, trade names, assembled workforce, licenses and certifications, non-compete clauses, proprietary technology, software, and others.
Certified stamp
By Will Hamilton December 14, 2018
For those of you who’ve been involved in a transaction where the only asset transferred is a certificate of need, you’ve probably found that market data is scarce for CON-only deals.
United States Department of Health and Human Services
By Darcy Devine December 4, 2018
On Monday, December 3, 2018, the Department of Health and Human Services (HHS) – in collaboration with the Departments of the Treasury and Labor, the Federal Trade Commission, and several offices within the White House – released a report detailing recommendations for improving choice and competition in the healthcare industry.
Model posing
By Will Hamilton November 26, 2018
One of the questions we get asked a lot is how valuations have changed over time.
Medical heart
By Will Hamilton November 19, 2018
One of the many benefits of tracking healthcare transactions closely and maintaining a very large database of deals where we can get reliable price to EBITDA and revenue multiples is that it provides insight into profit margins for segments where other financial benchmarking information is sparse.
By Will Hamilton November 16, 2018
The most important component of a valuation of an accountable care organization (or other multi-provider network that relies on risk-based shared savings models) is the revenue forecast, which involves “probability-adjusting” future shared savings payments in some manner.
Market saturation and utilization map
By Darcy Devine October 31, 2018
CMS' offers a helpful online tool that shows provider market saturation levels at the national-, state-, and county-levels for the following health services:
Show More